$AME

AMETEK, Inc. Stock 12‑Month Price Target Raised to $285.76, Implies 15% Upside

AMETEK's average stock price target increased from $284 to $285.76 by 17 analysts, with a range of $255 to $318. This implies a 15% upside from the Oct. 8 closing price. The consensus rating remains 'Buy' among 23 analysts, with 15 Buys, 7 Holds, and 1 Sell.

Original reporting
Published Oct 9, 2026, 7:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 7:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMETEK, Inc. Stock 12‑Month Price Target Raised to $285.76, Implies 15% Upside — source image
Decision brief

The 30-second read

$AMEBullishLow
01

Why it matters

A small upward revision may prompt modest buying but is unlikely to drive a significant price move.

02

Market read

The article provides a modestly bullish signal for AMETEK with limited broader market impact.

03

What to watch

No new earnings or guidance data; the move relies solely on analyst sentiment.

Relevance 5/10Novelty 4/10Timing: post‑release today

Background

Price target updates are routine analyst actions that can influence short‑term sentiment.

Company-level read

Ticker impact

$AMEBullishMedium confidence
Context

Analysts raised AMETEK's average price target to $285.76, implying ~15% upside.

Expected impact

likely upward pressure as traders price in the new upside potential

Evidence & confidence

A modest target increase from $284 to $285.76 signals a slight upgrade, which may attract short‑term buying.

Market effects

Minor positive signal for industrials and precision equipment sector.

U.S. market focus; limited broader regional effect.

Low global relevance beyond AMETEK investors.

Counterpoint

The target increase is marginal and may already be priced in, limiting upside.

Key entities

  • AMETEK, Inc.

    Industrial manufacturer whose price target was raised.

Related articles

$AMEMedAI 9/10

AMETEK’s (AME) $5B Deal Bets Big On A Hot Streak

AMETEK (AME) completed a $5.0B cash acquisition of Indicor Instrumentation. The company reported record Q2 sales of $2.04B, up 15% YoY, and raised full-year guidance. Indicor is expected to add $350M to 2026 sales and be modestly accretive to earnings. The deal aligns with AMETEK's existing portfolio and markets.

$RIMEMed

Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75

Carets Corp is exploring a potential sale, including its technology and patents. Algorhythm Holdings (RIME) and Biomerica (BMRA) are evaluating strategic alternatives. nVent Electric (NVT) acquired Maverick Power for $1.75B, with up to $550M more in performance-based payments. Descartes (DSGX) bought Tai for $100M, and Navitas (NVTS) acquired Claros for up to $232.8M. Booz Allen (BAH) completed a $720M acquisition, and Elastic (ESTC) acquired Deductive AI. BioXcel (BTAI) filed for Chapter 11 ban

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.